Clinical Trials Browser

INDUSTRY × Thyroid Neoplasms × Vemurafenib × Clear all

NCT02456701 2017-09-05

Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379

Phase 1 Completed

Thyroid Neoplasms